Correlation Engine 2.0
Clear Search sequence regions


  • activity (1)
  • bone marrow failure (2)
  • cell (1)
  • cell cycle (1)
  • dna damage (3)
  • dna repair (2)
  • FANCD2 (2)
  • Fanconi anemia (11)
  • gene (3)
  • humans (1)
  • marrow (1)
  • patients (1)
  • phase (1)
  • proteins FANCI (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    Fanconi anemia (FA) is an inherited blood disorder that causes bone marrow failure and high predisposition to cancers. The FA pathway guards the cell's genome stability by orchestrating the repair of interstrand cross-linking during the S phase of the cell cycle, preventing the chromosomal instability that is a key event in bone marrow failure syndrome. Central to the FA pathway is loss of monoubiquitinated forms of the Fanconi proteins FANCI and FANCD2, a process that is normally mediated by a "core complex" of seven other Fanconi proteins. Each protein, when mutated, can cause FA. The FA core-complex-catalyzed reaction is critical for signaling DNA cross-link damage such as that induced by chemotherapies. Here, we present a perspective on the current understanding of FANCI and FANCD2 monoubiquitination-mediated DNA repair. Our recent biochemical reconstitution of the monoubiquitination (and deubiquitination) reactions creates a paradigm for understanding FA. Further biochemical analysis will create new opportunities to address the leukemic phenotype of FA patients. Copyright © 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

    Citation

    Winnie Tan, Andrew J Deans. A defined role for multiple Fanconi anemia gene products in DNA-damage-associated ubiquitination. Experimental hematology. 2017 Jun;50:27-32

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28315701

    View Full Text